Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2421)	8/3/2009 11:30:32 AM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

AGEN was up > 15% earlier, but is up only 14.69% at present<g> Volume of 3,754,900 is still below its ADV. bigcharts.marketwatch.com On Friday it announced that it had sold in a private placement 5,000,000 shares of its common stock at a price of $2.00, resulting in gross proceeds of $10M.The investor will also receive six-month warrants to purchase up to 2.5M additional shares of common stock at an exercise price of $2 and 4 year warrants to purchase up to approximately 2.2M additional shares of common stock at an exercise price of $2.30 <g> Will see if it can make gooud use of the $10M and the stock can get to the $5 level,<g> bigcharts.marketwatch.com At ASCO in June, it announced results of an interim analysis from the ongoing global patient survival registry, which showed that patients with kidney cancer at intermediate risk of disease recurrence demonstrated an approximately 46% lower risk of death when treated with Oncophage.<g> Bernard